Genfit S.A. (GNFT)
NASDAQ: GNFT · Real-Time Price · USD
5.59
-0.06 (-1.06%)
Oct 24, 2024, 4:00 PM EDT - Market closed
Genfit Market Cap
Genfit has a market cap or net worth of $275.49 million as of October 24, 2024. Its market cap has increased by 78.08% in one year.
Market Cap
275.49M
Enterprise Value
282.13M
1-Year Change
78.08%
Ranking
Category
Stock Price
$5.59
Market Cap Chart
Since March 27, 2019, Genfit's market cap has decreased from $802.20M to $275.49M, a decrease of -65.66%. That is a compound annual growth rate of -17.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2024 | 284.50M | 48.25% |
| Dec 29, 2023 | 191.90M | -12.21% |
| Dec 30, 2022 | 218.60M | 12.45% |
| Dec 31, 2021 | 194.40M | 4.24% |
| Dec 31, 2020 | 186.50M | -74.10% |
| Dec 31, 2019 | 720.10M | -10.23% |
| Mar 27, 2019 | 802.20M | - |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanara MedTech | 297.40M |
| Atea Pharmaceuticals | 294.63M |
| Rezolute | 291.94M |
| Lyell Immunopharma | 291.84M |
| Immutep | 291.63M |
| AngioDynamics | 286.88M |
| Jasper Therapeutics | 286.77M |
| PepGen | 285.81M |